nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—CYP2D6—Parkinson's disease	0.896	1	CbGaD
Bisoprolol—Alprenolol—HTR1A—Parkinson's disease	0.00127	0.126	CrCbGaD
Bisoprolol—Pindolol—HTR1A—Parkinson's disease	0.00109	0.109	CrCbGaD
Bisoprolol—Betaxolol—CYP2D6—Parkinson's disease	0.000917	0.0914	CrCbGaD
Bisoprolol—Acebutolol—CYP2D6—Parkinson's disease	0.000838	0.0836	CrCbGaD
Bisoprolol—Oxprenolol—CYP2D6—Parkinson's disease	0.000832	0.083	CrCbGaD
Bisoprolol—Alprenolol—CYP2D6—Parkinson's disease	0.000761	0.0759	CrCbGaD
Bisoprolol—Metoprolol—CYP2D6—Parkinson's disease	0.000708	0.0705	CrCbGaD
Bisoprolol—Pindolol—CYP2D6—Parkinson's disease	0.000655	0.0653	CrCbGaD
Bisoprolol—Atenolol—ABCB1—Parkinson's disease	0.000649	0.0647	CrCbGaD
Bisoprolol—Acebutolol—ABCB1—Parkinson's disease	0.000599	0.0597	CrCbGaD
Bisoprolol—Propranolol—HTR1A—Parkinson's disease	0.000596	0.0594	CrCbGaD
Bisoprolol—Metoprolol—ABCB1—Parkinson's disease	0.000505	0.0504	CrCbGaD
Bisoprolol—Propranolol—CYP2D6—Parkinson's disease	0.000357	0.0356	CrCbGaD
Bisoprolol—Propranolol—ABCB1—Parkinson's disease	0.000255	0.0254	CrCbGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000206	0.00218	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000206	0.00218	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000206	0.00218	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000205	0.00217	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—GPR37—Parkinson's disease	0.000201	0.00213	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—DGKQ—Parkinson's disease	0.000201	0.00213	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000201	0.00213	CbGpPWpGaD
Bisoprolol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.0002	0.00212	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000199	0.00211	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000195	0.00206	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000188	0.002	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000187	0.00198	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000184	0.00195	CbGpPWpGaD
Bisoprolol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000183	0.00194	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000183	0.00194	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00018	0.00191	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00018	0.00191	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000176	0.00187	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000176	0.00187	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—GRK5—Parkinson's disease	0.000172	0.00182	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—GRK5—Parkinson's disease	0.000168	0.00178	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—HTR1A—Parkinson's disease	0.000162	0.00172	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000161	0.0017	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—TAC1—Parkinson's disease	0.00016	0.00169	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—HTR1A—Parkinson's disease	0.000159	0.00168	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000158	0.00168	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—DRD1—Parkinson's disease	0.000157	0.00166	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—TAC1—Parkinson's disease	0.000156	0.00166	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—GRK5—Parkinson's disease	0.000156	0.00165	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—GRM4—Parkinson's disease	0.000154	0.00163	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—DRD1—Parkinson's disease	0.000153	0.00162	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—GRK5—Parkinson's disease	0.000153	0.00162	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—DRD3—Parkinson's disease	0.000152	0.00161	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—GRM4—Parkinson's disease	0.000151	0.0016	CbGpPWpGaD
Bisoprolol—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000151	0.0016	CbGpPWpGaD
Bisoprolol—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000149	0.00158	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—DRD3—Parkinson's disease	0.000148	0.00157	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000147	0.00156	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—VPS35—Parkinson's disease	0.000147	0.00156	CbGpPWpGaD
Bisoprolol—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000147	0.00155	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PENK—Parkinson's disease	0.000146	0.00155	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000144	0.00153	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000144	0.00153	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—VPS35—Parkinson's disease	0.000144	0.00152	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000143	0.00152	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PENK—Parkinson's disease	0.000143	0.00151	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000141	0.0015	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—GRM4—Parkinson's disease	0.00014	0.00148	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—DRD2—Parkinson's disease	0.000137	0.00145	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—HTR7—Parkinson's disease	0.000137	0.00145	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—GRM4—Parkinson's disease	0.000137	0.00145	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—DRD2—Parkinson's disease	0.000134	0.00142	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—HTR7—Parkinson's disease	0.000134	0.00142	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PDYN—Parkinson's disease	0.000134	0.00142	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PENK—Parkinson's disease	0.000133	0.00141	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PDYN—Parkinson's disease	0.000131	0.00139	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PENK—Parkinson's disease	0.00013	0.00138	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000126	0.00134	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000124	0.00132	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000123	0.00131	CbGpPWpGaD
Bisoprolol—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.000123	0.00131	CbGpPWpGaD
Bisoprolol—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.000123	0.0013	CbGpPWpGaD
Bisoprolol—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.000122	0.0013	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GPR37—Parkinson's disease	0.000122	0.00129	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—DGKQ—Parkinson's disease	0.000122	0.00129	CbGpPWpGaD
Bisoprolol—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000122	0.00129	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	0.000122	0.00129	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PDYN—Parkinson's disease	0.000121	0.00129	CbGpPWpGaD
Bisoprolol—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000121	0.00128	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	0.000119	0.00126	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	0.000119	0.00126	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	0.000119	0.00126	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—GRM5—Parkinson's disease	0.000113	0.0012	CbGpPWpGaD
Bisoprolol—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	0.000113	0.00119	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000111	0.00118	CbGpPWpGaD
Bisoprolol—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000111	0.00118	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	0.00011	0.00117	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—EDN1—Parkinson's disease	0.00011	0.00116	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000109	0.00115	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	0.000107	0.00114	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000106	0.00113	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000106	0.00112	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000105	0.00111	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000103	0.00109	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	9.73e-05	0.00103	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—RIT2—Parkinson's disease	9.73e-05	0.00103	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—HTR2A—Parkinson's disease	9.61e-05	0.00102	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	9.6e-05	0.00102	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—ADORA2A—Parkinson's disease	9.59e-05	0.00102	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	9.51e-05	0.00101	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	9.4e-05	0.000996	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	9.39e-05	0.000994	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GRK5—Parkinson's disease	9.22e-05	0.000977	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—HTR1A—Parkinson's disease	9.17e-05	0.000971	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—TAC1—Parkinson's disease	9.03e-05	0.000956	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	9.02e-05	0.000955	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	8.97e-05	0.00095	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—DRD1—Parkinson's disease	8.85e-05	0.000938	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	8.83e-05	0.000936	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	8.66e-05	0.000918	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—DRD3—Parkinson's disease	8.57e-05	0.000908	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	8.39e-05	0.000889	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HTR1A—Parkinson's disease	8.32e-05	0.000882	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GRM4—Parkinson's disease	8.27e-05	0.000876	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—TAC1—Parkinson's disease	8.2e-05	0.000869	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	8.14e-05	0.000863	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	8.09e-05	0.000857	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—COMT—Parkinson's disease	8.06e-05	0.000854	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—DRD1—Parkinson's disease	8.04e-05	0.000852	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	8.02e-05	0.00085	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	8.02e-05	0.00085	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—ADRBK1—Parkinson's disease	8.01e-05	0.000848	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	8.01e-05	0.000848	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ND3—Parkinson's disease	8e-05	0.000847	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—MCCC1—Parkinson's disease	8e-05	0.000847	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	7.95e-05	0.000842	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	7.91e-05	0.000838	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	7.86e-05	0.000833	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PENK—Parkinson's disease	7.84e-05	0.00083	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MAG—Parkinson's disease	7.84e-05	0.00083	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	7.83e-05	0.00083	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—DRD3—Parkinson's disease	7.79e-05	0.000825	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—HTR7—Parkinson's disease	7.75e-05	0.000822	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—DRD2—Parkinson's disease	7.75e-05	0.000822	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PENK—Parkinson's disease	7.67e-05	0.000812	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MAG—Parkinson's disease	7.67e-05	0.000812	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	7.62e-05	0.000807	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	7.59e-05	0.000804	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	7.59e-05	0.000804	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—TALDO1—Parkinson's disease	7.52e-05	0.000796	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—OMD—Parkinson's disease	7.52e-05	0.000796	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	7.37e-05	0.000781	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	7.27e-05	0.00077	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—ADRBK1—Parkinson's disease	7.27e-05	0.00077	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PDYN—Parkinson's disease	7.17e-05	0.00076	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	7.13e-05	0.000755	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	7.11e-05	0.000754	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HTR7—Parkinson's disease	7.04e-05	0.000746	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—DRD2—Parkinson's disease	7.04e-05	0.000746	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	7.01e-05	0.000743	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	6.89e-05	0.00073	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	6.89e-05	0.00073	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GCH1—Parkinson's disease	6.8e-05	0.00072	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GFAP—Parkinson's disease	6.74e-05	0.000714	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GRM5—Parkinson's disease	6.67e-05	0.000706	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	6.59e-05	0.000699	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	6.52e-05	0.000691	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—EDN1—Parkinson's disease	6.21e-05	0.000658	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	6.07e-05	0.000643	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GBA—Parkinson's disease	6.06e-05	0.000642	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—DBH—Parkinson's disease	6.06e-05	0.000642	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—FBP1—Parkinson's disease	6.06e-05	0.000642	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FGF20—Parkinson's disease	5.84e-05	0.000619	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	5.72e-05	0.000606	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ADORA2A—Parkinson's disease	5.67e-05	0.0006	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—EDN1—Parkinson's disease	5.64e-05	0.000597	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	5.54e-05	0.000587	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	5.52e-05	0.000584	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—HTR2A—Parkinson's disease	5.43e-05	0.000575	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	5.31e-05	0.000563	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—INSR—Parkinson's disease	5.23e-05	0.000554	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—MCCC1—Parkinson's disease	5.23e-05	0.000554	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ND3—Parkinson's disease	5.23e-05	0.000554	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—INSR—Parkinson's disease	5.12e-05	0.000542	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FGB—Parkinson's disease	4.94e-05	0.000524	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HTR2A—Parkinson's disease	4.93e-05	0.000522	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR1A—Parkinson's disease	4.92e-05	0.000521	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—TALDO1—Parkinson's disease	4.92e-05	0.000521	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—OMD—Parkinson's disease	4.92e-05	0.000521	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TAC1—Parkinson's disease	4.84e-05	0.000513	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FGB—Parkinson's disease	4.84e-05	0.000512	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	4.82e-05	0.000511	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	4.81e-05	0.00051	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—DRD1—Parkinson's disease	4.75e-05	0.000503	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	4.74e-05	0.000502	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.66e-05	0.000494	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	4.65e-05	0.000492	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—DRD3—Parkinson's disease	4.6e-05	0.000487	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	4.5e-05	0.000477	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—DDC—Parkinson's disease	4.45e-05	0.000471	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GCH1—Parkinson's disease	4.45e-05	0.000471	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ADRBK1—Parkinson's disease	4.3e-05	0.000455	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	4.2e-05	0.000445	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTA4—Parkinson's disease	4.2e-05	0.000445	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR7—Parkinson's disease	4.16e-05	0.000441	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—DRD2—Parkinson's disease	4.16e-05	0.000441	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	4.07e-05	0.000431	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	4.07e-05	0.000431	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GBA—Parkinson's disease	3.96e-05	0.00042	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—DBH—Parkinson's disease	3.96e-05	0.00042	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.96e-05	0.00042	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.78e-05	0.000401	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.74e-05	0.000397	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	3.49e-05	0.000369	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	3.41e-05	0.000361	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	3.37e-05	0.000357	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	3.33e-05	0.000353	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	3.3e-05	0.000349	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	3.26e-05	0.000345	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NGF—Parkinson's disease	3.06e-05	0.000324	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NGF—Parkinson's disease	2.99e-05	0.000317	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	2.91e-05	0.000309	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—DDC—Parkinson's disease	2.91e-05	0.000308	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	2.85e-05	0.000302	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.75e-05	0.000291	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.73e-05	0.000289	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APOE—Parkinson's disease	2.71e-05	0.000287	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APOE—Parkinson's disease	2.65e-05	0.000281	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.54e-05	0.00027	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.52e-05	0.000267	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—TH—Parkinson's disease	2.48e-05	0.000263	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.47e-05	0.000262	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.45e-05	0.000259	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.38e-05	0.000252	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—INS—Parkinson's disease	2.31e-05	0.000245	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—INS—Parkinson's disease	2.26e-05	0.00024	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—COMT—Parkinson's disease	2.11e-05	0.000223	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.1e-05	0.000222	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.09e-05	0.000222	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.07e-05	0.000219	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.99e-05	0.00021	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.93e-05	0.000204	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.85e-05	0.000196	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.82e-05	0.000193	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.79e-05	0.000189	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	1.72e-05	0.000183	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	1.71e-05	0.000181	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.7e-05	0.000181	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	1.69e-05	0.000179	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	1.67e-05	0.000177	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.66e-05	0.000176	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.65e-05	0.000174	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—TH—Parkinson's disease	1.62e-05	0.000172	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—APOE—Parkinson's disease	1.59e-05	0.000168	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	1.58e-05	0.000168	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.56e-05	0.000165	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	1.55e-05	0.000164	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—COMT—Parkinson's disease	1.38e-05	0.000146	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.37e-05	0.000145	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.37e-05	0.000145	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—INS—Parkinson's disease	1.36e-05	0.000144	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.35e-05	0.000143	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.3e-05	0.000138	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.26e-05	0.000134	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.21e-05	0.000128	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.11e-05	0.000118	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—APOE—Parkinson's disease	1.04e-05	0.00011	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IL6—Parkinson's disease	1.01e-05	0.000107	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IL6—Parkinson's disease	9.89e-06	0.000105	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—INS—Parkinson's disease	8.86e-06	9.39e-05	CbGpPWpGaD
